A detailed history of Petredis Investment Advisors LLC transactions in Amgen Inc stock. As of the latest transaction made, Petredis Investment Advisors LLC holds 1,556 shares of AMGN stock, worth $500,736. This represents 0.05% of its overall portfolio holdings.

Number of Shares
1,556
Previous 1,563 0.45%
Holding current value
$500,736
Previous $488 Million 2.66%
% of portfolio
0.05%
Previous 0.05%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$309.38 - $337.38 $2,165 - $2,361
-7 Reduced 0.45%
1,556 $501 Million
Q2 2024

Jul 16, 2024

BUY
$262.75 - $319.31 $6,043 - $7,344
23 Added 1.49%
1,563 $488 Million
Q4 2022

Feb 06, 2023

BUY
$229.03 - $291.01 $352,706 - $448,155
1,540 New
1,540 $404 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $172B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Petredis Investment Advisors LLC Portfolio

Follow Petredis Investment Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Petredis Investment Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Petredis Investment Advisors LLC with notifications on news.